They both likely accomplish this by improving cardiovascular disease risk factors such as improving blood sugar control, improving blood pressure, promoting weight less, reducing inflammation, and improving blood vessel function. The researchers reviewed 601 published trials of older people to investigate whether the efficacy of three medications DPP-4 inhibitors, SGLT2 inhibitors, and GLP-1 agonists was affected by the age or sex of people with type 2 diabetes
Together, these effects help reduce calorie intake and support weight loss over time
In their second study, the team looked specifically at what might happen if Medicare began covering GLP-1 drugs for obesity treatment
Does TB-500 Repair Heart Damage
When paired with calorie control and physical activity, this process may improve the bodys ability to utilize stored fat
Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood-brain barrier and enhance neurogenesis